Join to View Full Profile
1330 E 6th StSuite 204Weslaco, TX 78596
Phone+1 956-969-0021
Fax+1 956-698-9744
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Habib Ghaddar, MD is an oncologist in Weslaco, Texas. He is currently licensed to practice medicine in Texas.
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1992 - 1995
- Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1989 - 1992
- American University of Beirut Faculty of MedicineClass of 1989
Certifications & Licensure
- TX State Medical License 1992 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsResults of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.Marcus A. Neubauer, Craig H. Reynolds, Marcos G. Joppert, Thomas Whittaker, Habib M. Ghaddar
Clinical Lung Cancer. 2005-01-01 - 112 citationsPhase I Trial of the Angiogenesis Inhibitor TNP-470 for Progressive Androgen-independent Prostate CancerChristopher J. Logothetis, Kenneth K. Wu, Laury Finn, Danai D. Daliani, William D. Figg
Clinical Cancer Research. 2001-05-01 - 33 citationsCorrelation of Factor VIIa Values With Factor VII Gene Polymorphism, Fasting and Postprandial Triglyceride Levels, and Subclinical Carotid AtherosclerosisHabib M. Ghaddar, Aaron R. Folsom, Nena Aleksic, Leonard B. Hearne, Lloyd E. Chambless
Circulation. 1998-12-22
Press Mentions
- Colonoscopy: Is It Worth It?March 19th, 2018
- An Inspiring Experience at Cancer Control in Primary Care Course in BhutanMarch 15th, 2018